Co-Authors
This is a "connection" page, showing publications co-authored by Hongzhou Lu and Tongyu Zhu.
Connection Strength
1.819
-
Pre-optimized phage therapy on secondary Acinetobacter baumannii infection in four critical COVID-19 patients. Emerg Microbes Infect. 2021 Dec; 10(1):612-618.
Score: 0.245
-
Epigenetic Landscapes of Single-Cell Chromatin Accessibility and Transcriptomic Immune Profiles of T Cells in COVID-19 Patients. Front Immunol. 2021; 12:625881.
Score: 0.233
-
Epidemiology and clinical course of COVID-19 in Shanghai, China. Emerg Microbes Infect. 2020 Dec; 9(1):1537-1545.
Score: 0.229
-
A clinical pilot study on the safety and efficacy of aerosol inhalation treatment of IFN-? plus TFF2 in patients with moderate COVID-19. EClinicalMedicine. 2020 Aug; 25:100478.
Score: 0.224
-
Potential for jaktinib hydrochloride to treat cytokine storms in patients with COVID-19. Biosci Trends. 2020 Jul 17; 14(3):161-167.
Score: 0.222
-
COVID-19 infection: the China and Italy perspectives. Cell Death Dis. 2020 06 08; 11(6):438.
Score: 0.222
-
Clinical progression of patients with COVID-19 in Shanghai, China. J Infect. 2020 05; 80(5):e1-e6.
Score: 0.218
-
Correlation Between Early Plasma Interleukin 37 Responses With Low Inflammatory Cytokine Levels and Benign Clinical Outcomes in Severe Acute Respiratory Syndrome Coronavirus 2 Infection. J Infect Dis. 2021 02 24; 223(4):568-580.
Score: 0.058
-
Evaluating the Association of Clinical Characteristics With Neutralizing Antibody Levels in Patients Who Have Recovered From Mild COVID-19 in Shanghai, China. JAMA Intern Med. 2020 10 01; 180(10):1356-1362.
Score: 0.057
-
An open-label, randomized trial of the combination of IFN-? plus TFF2 with standard care in the treatment of patients with moderate COVID-19. EClinicalMedicine. 2020 Oct; 27:100547.
Score: 0.056
-
CT quantification of pneumonia lesions in early days predicts progression to severe illness in a cohort of COVID-19 patients. Theranostics. 2020; 10(12):5613-5622.
Score: 0.055